MLXIPL and metabolic dysfunction-associated steatotic liver disease: Additionally, we observed the downregulation of the carbohydrate response element-binding protein (ChREBP), a gene that increases the likelihood of NAFLD [40]; ACC2, a gene playing a role in fatty acid synthesis [41]; AND peroxisome proliferator-activated receptor gamma (PPARγ), an adipogenic gene [42].